Artificial Intelligence in Nephrology
Apr 25,26 | 01:44 EST
Kidney diseases often develop silently, with the body compensating so effectively that patients may remain unaware of the problem for years. Symptoms typically appear only at advanced stages and are often nonspecific, such as fatigue or swelling. This is why modern nephrology is increasingly focused not only on diagnosis, but also on predicting disease progression. Artificial intelligence is playing a growing role in this shift. By analyzing complex clinical data, AI models can estimate the risk of specific outcomes—such as whether a patient’s condition may go into remission—allowing clinicians to view disease as a dynamic, predictable process rather than a set of isolated parameters. Different types of models are used depending on the data. Classical approaches such as logistic regression, random forests, and XGBoost perform well with structured clinical data, while neural networks are better suited to more complex inputs like medical images. At the same time, experts emphasize that the clinical usefulness and interpretability of models remain more important than their complexity. A particularly promising direction is the integration of AI with advanced biological analyses, such as proteomics and metabolomics. This combination makes it possible to detect very early molecular changes—before symptoms appear or standard tests show abnormalities—opening the door to earlier diagnosis and more accurate prediction of disease progression. For patients, these advances mean earlier detection, better prognoses, and more personalized treatment. However, artificial intelligence remains a support tool, with final clinical decisions still made by physicians.
... read more
